Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-26 @ 2:48 AM
Study NCT ID:
NCT01922102
Status:
COMPLETED
Last Update Posted:
2019-06-24
First Post:
2013-08-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-12
First Submit QC Date:
None
Study First Post Date:
2013-08-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-11
Results First Submit QC Date:
None
Results First Post Date:
2019-06-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-31
Last Update Post Date:
2019-06-24
Last Update Post Date Type:
ACTUAL